2024. Integrated Safety Analysis of Abrocitinib in 635 Adolescent Patients With Moderate-To-Severe Atopic Dermatitis With Over 1000 Patient-Years of Exposure. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s379. DOI:https://doi.org/10.25251/skin.8.supp.379.